TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22913571

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) intervention including prescribing indicator feedback reports and small group discussions with peers and a trained facilitator.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (waitlisted to receive the intervention 6 months later).
Number of subjects: 0
Study: 20200268

Group type: EXPERIMENTAL
Intervention: Sergliflozin etabonate 500 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sergliflozin etabonate 1000 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sergliflozin etabonate 500 or 1000 mg
Number of subjects: 18
Study: 17944916

Group type: EXPERIMENTAL
Intervention: Revealed high‐risk HPV test result in addition to cervical cytology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concealed high‐risk HPV test result
Number of subjects: 0
Study: 15657326

Group type: EXPERIMENTAL
Intervention: 0.625 mg/d of conjugated equine estrogens (CEE)
Number of subjects: 22579

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E + P), given as CEE plus 2.5 mg/d of medroxyprogesterone acetate
Number of subjects: 22579

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E + P)
Number of subjects: 22579
Study: 12870569

Group type: EXPERIMENTAL
Intervention: Quetiapine (600 mg/day)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Haloperidol (20 mg/day)
Number of subjects: 269
Study: 10492316

Group type: EXPERIMENTAL
Intervention: Subcutaneous calcium-heparin (12,500 IU/day)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 8758169

Group type: EXPERIMENTAL
Intervention: Epidural infusion of 0.06% bupivacaine with fentanyl 4 micrograms.ml‐1 (group F)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural infusion of 0.06% bupivacaine with pethidine 1.5 mg.ml‐1 (group P)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural infusion rates in both groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Side effects and effect on pulmonary function
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural 'top-ups' by an anaesthetist
Number of subjects: 40
Study: 30138003

Group type: EXPERIMENTAL
Intervention: Δ9‐THC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 27298414

Group type: EXPERIMENTAL
Intervention: Tasquinimod
Number of subjects: 1245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1245
Study: 25175921

Group type: EXPERIMENTAL
Intervention: Prehospital ticagrelor administration
Number of subjects: 1862

Group type: COMPARATOR
Intervention: In-hospital ticagrelor administration
Number of subjects: 1862
Study: 22473814

Group type: EXPERIMENTAL
Intervention: Organic yogurt
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional yogurt
Number of subjects: 6

Group type: COMPARATOR
Intervention: Labeled conventional yogurt
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Blind and labeled tests
Number of subjects: 6
Study: 19800815

Group type: EXPERIMENTAL
Intervention: Amiodarone (150 mg in 10 mL of normal saline)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline (10 mL)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Amiodarone (150 mg)
Number of subjects: 34
Study: 17922444

Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agents for hemoglobin normalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New agents for calcium-phosphate metabolism (phosphate binders not containing calcium and aluminum, vitamin D analogs with lower calcemic activity, calcimimetics)
Number of subjects: 0
Study: 16392704

Group type: EXPERIMENTAL
Intervention: Green tea extracts/powder containing 544 mg polyphenols (456 mg catechins) daily for 2 months
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 66
Study: 12480476

Group type: EXPERIMENTAL
Intervention: Visual context supporting the preferred interpretation of the ambiguous phrase (e.g., 'Put the apple on the towel in the box')
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual context supporting the less-preferred interpretation of the ambiguous phrase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of prerecorded digitized speech to eliminate prosodic differences
Number of subjects: 0
Study: 9801935

Group type: EXPERIMENTAL
Intervention: Dry visco-elastic polymer pad (Action Products Inc.)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Standard operating table mattress
Number of subjects: 446
Study: 7897161

Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 50 mg hydroxyzine
Number of subjects: 13
Study: 2523647

Group type: EXPERIMENTAL
Intervention: Captopril plus Isradipine (1.25 mg twice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Captopril plus Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Captopril plus Hydrochlorothiazide (12.5 mg per day)
Number of subjects: 28
Study: 326384

Group type: EXPERIMENTAL
Intervention: CMF chemotherapy for 12 monthly cycles
Number of subjects: 386

Group type: COMPARATOR
Intervention: Control group (radical surgery only)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: CMF chemotherapy
Number of subjects: 386
Study: 31229663

Group type: EXPERIMENTAL
Intervention: RF ablation of the basivertebral nerve (BVN)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 140
Study: 28574669

Group type: EXPERIMENTAL
Intervention: Social ABCs intervention
Number of subjects: 63

Group type: COMPARATOR
Intervention: Service-as-usual (control)
Number of subjects: 63
Study: 25102198

Group type: EXPERIMENTAL
Intervention: 16 Gray Stereotactic Radiotherapy (SRT)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 24 Gray Stereotactic Radiotherapy (SRT)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Sham Stereotactic Radiotherapy
Number of subjects: 230
Study: 23197840

Group type: EXPERIMENTAL
Intervention: Increased anxiety symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Increased somatic depressive symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Concurrent somatic depressive symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Concurrent affective depressive symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Concurrent anxiety symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Preexisting somatic depressive symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Preexisting affective depressive symptoms
Number of subjects: 121
Study: 21636159

Group type: EXPERIMENTAL
Intervention: Overground walking training at ventilatory threshold velocity for 20-60 min/session three times/week for 12 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 19
Study: 19932320

Group type: COMPARATOR
Intervention: Viewing 0 confederates using PPE
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Viewing 1 confederate using PPE
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Viewing 2 confederates using PPE
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Viewing 3 confederates using PPE
Number of subjects: 64
Study: 16843739

Group type: EXPERIMENTAL
Intervention: Indapamide quantification method using LC-ESI-MS
Number of subjects: 0
Study: 14505443

Group type: EXPERIMENTAL
Intervention: Routine hospice services and clinical music therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine hospice services only
Number of subjects: 80
Study: 10866713

Group type: EXPERIMENTAL
Intervention: Ephedrine (0.08 mg x kg‐1 intravenously)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Etilefrine (0.02 mg x kg‐1 intravenously)
Number of subjects: 67
Study: 9109708

Group type: EXPERIMENTAL
Intervention: Narrow-band red light phototherapy at 660 nm for 4.4 minutes three times a day for 14 days (total dose 6 joules per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham illumination (placebo)
Number of subjects: 60
Study: 1470889

Group type: EXPERIMENTAL
Intervention: Taurolin (topical application)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Chlortetracycline (Aureomycin, topical application)
Number of subjects: 200
Study: 2863090

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aqueous nasal spray
Number of subjects: 49

Group type: COMPARATOR
Intervention: Terfenadine tablets
Number of subjects: 49
Study: 31451122

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 122
Study: 30735328

Group type: EXPERIMENTAL
Intervention: Allele-specific RT-PCR followed by electrophoretic detection
Number of subjects: 1284

Group type: COMPARATOR
Intervention: Sanger sequencing
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: Electrophoretic detection of PCR results
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: Pyrosequencing of DNA
Number of subjects: 1284
Study: 26724987

Group type: EXPERIMENTAL
Intervention: Educational intervention based on cognitive-behavioural principles (including a written document for home reading, sharing, clarifying doubts, and restructuring beliefs and goals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Back Schools program (control group)
Number of subjects: 0
Study: 24485296

Group type: EXPERIMENTAL
Intervention: Balugrastim 40 mg
Number of subjects: 304

Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 304
Study: 22606044

Group type: EXPERIMENTAL
Intervention: Donepezil plus natural hirudin (3 g/day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Donepezil (5 mg/day for the first 4 weeks and 10 mg/day thereafter)
Number of subjects: 84
Study: 20537124

Group type: EXPERIMENTAL
Intervention: Internet group (n = 101) that monitored asthma control weekly with the ACQ on the Internet and adjusted treatment using a self‐management algorithm supervised by an asthma nurse specialist
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Internet group (n = 101)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care group (n = 99)
Number of subjects: 200
Study: 18178608

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 16350630

Group type: EXPERIMENTAL
Intervention: Breathing group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 12136399

Group type: EXPERIMENTAL
Intervention: 5-methyltetrahydrofolate (5-MTHF, 1 microg/100 ml FAV/min)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Serotonin (stimulator of nitric oxide-dependent vasodilation)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sodium nitroprusside (stimulator of endothelium-independent vasodilation)
Number of subjects: 23
Study: 10654798

Group type: EXPERIMENTAL
Intervention: 111In‐labelled resin (150‐300 microm) administered in the morning (0800h)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 99mTc‐labelled non‐disintegrating capsule (22 x 8 mm) administered in the morning (0800h)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 111In‐labelled resin (150‐300 microm) administered in the evening (1700h)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 99mTc‐labelled non‐disintegrating capsule (22 x 8 mm) administered in the evening (1700h)
Number of subjects: 18
Study: 8719863

Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination (IUI) in natural cycles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation (COH) with IUI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mild stimulation COH
Number of subjects: 0
Study: 2194270

Group type: EXPERIMENTAL
Intervention: IVIG (1 g/d)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (albumin)
Number of subjects: 240
Study: 7008062

Group type: EXPERIMENTAL
Intervention: Prostacyclin infusion at a dosage of 8 ng/kg/min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle infusion (control)
Number of subjects: 0
Study: 31687839

Group type: EXPERIMENTAL
Intervention: Infertile patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Azoospermic patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fertile men
Number of subjects: 100
Study: 30601837

Group type: EXPERIMENTAL
Intervention: Reappraisal (twice)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Reappraisal followed by rumination
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Rumination followed by reappraisal
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Rumination (twice)
Number of subjects: 156
Study: 29602751

Group type: EXPERIMENTAL
Intervention: Ivermectin 600 μg/kg per day for 3 days
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Ivermectin 300 μg/kg per day for 3 days
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 27989639

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment (ET)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: VUR grade ≤2
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: VUR grade >2
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Persistent bilateral grade 5 VUR
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: High PVR at baseline
Number of subjects: 77
Study: 26294205

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) daily program from 20 to 36 weeks' gestation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 96
Study: 24267940

Group type: EXPERIMENTAL
Intervention: Graduate-to-undergraduate student mentoring (up to 20 hours by registered nurses)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no mentoring)
Number of subjects: 51
Study: 21392746

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted colorectal resection
Number of subjects: 52

Group type: COMPARATOR
Intervention: Open colorectal resection
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 52
Study: 18339335

Group type: EXPERIMENTAL
Intervention: Transtheoretical case management approach
Number of subjects: 0
Study: 16841630

Group type: EXPERIMENTAL
Intervention: Olanzapine-fluoxetine combination
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Olanzapine monotherapy
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Switched group
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 376
Study: 12700625

Group type: EXPERIMENTAL
Intervention: Bread with cumulating 5% reductions in sodium content each week for six consecutive weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Bread with usual sodium content for six consecutive weeks
Number of subjects: 110
Study: 10688033

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (HCG) treatment
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: HCG treatment
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Inguinal herniography
Number of subjects: 310
Study: 9095326

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 111

Group type: COMPARATOR
Intervention: Combination regimen (metoclopramide, dexamethasone, lorazepam, orphenadrine)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Combination regimen
Number of subjects: 111
Study: 8459263

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis and immunoprophylaxis (thymostimulin 70 mg i.m. per day for 7 days + 2 g cefotetan at induction)
Number of subjects: 859

Group type: COMPARATOR
Intervention: Chemoprophylaxis only (2 g cefotetan at induction)
Number of subjects: 859

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis and immunoprophylaxis (thymostimulin + cefotetan)
Number of subjects: 859
Study: 3516016

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine, 3 mg/kg, followed by an infusion of 0.05 mg X kg‐1 X min‐1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine, 3 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (fentanyl only)
Number of subjects: 20
Study: 31443443

Group type: EXPERIMENTAL
Intervention: Types of activity areas in parks
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Psychosocial factors (self-efficacy and perceived barriers)
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Interaction between perceived park features and self-efficacy
Number of subjects: 628
Study: 28899879

Group type: EXPERIMENTAL
Intervention: Higher protein intake (2.4 g/kg/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lower protein intake (1.2 g/kg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Energy balance (control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Energy restriction (ER) rested legs
Number of subjects: 24

Group type: COMPARATOR
Intervention: Energy restriction (ER) exercised legs
Number of subjects: 24
Study: 27378474

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/day
Number of subjects: 99
Study: 26385950

Group type: EXPERIMENTAL
Intervention: Fish meal - vitamin C (n = 50)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (n = 50)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Vitamin C (n = 50)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Malaria parasitemia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High CRP
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Hookworm infestation
Number of subjects: 150
Study: 21901389

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Nutrition education program (NEP)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual supportive care (UC)
Number of subjects: 172
Study: 19896321

Group type: EXPERIMENTAL
Intervention: Absolute frequencies
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Combined descriptors
Number of subjects: 134

Group type: COMPARATOR
Intervention: Frequency bands
Number of subjects: 134

Group type: COMPARATOR
Intervention: Numeric descriptors only
Number of subjects: 134
Study: 17327141

Group type: EXPERIMENTAL
Intervention: MUFA diet
Number of subjects: 151

Group type: COMPARATOR
Intervention: SFA diet
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Fish oil (3.6g n‐3 FA/day)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 15929948

Group type: EXPERIMENTAL
Intervention: Automated sputum cytology
Number of subjects: 2480

Group type: COMPARATOR
Intervention: Conventional sputum cytology
Number of subjects: 2480
Study: 12766602

Group type: EXPERIMENTAL
Intervention: 99mTc‐rhenium sulphide colloid (7.4 MBq for 1 day protocol, 37 MBq for 2 day protocol)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1 day protocol (morning injection and afternoon surgery)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 day protocol (day before afternoon injection and morning surgery)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lower doses of 99mTc‐rhenium sulphide colloid
Number of subjects: 60
Study: 10487404

Group type: EXPERIMENTAL
Intervention: Anethole trithione (AT) - 6 tablets per day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (artificial saliva)
Number of subjects: 45
Study: 7588175

Group type: EXPERIMENTAL
Intervention: Antidepressant drugs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous administration of antidepressants
Number of subjects: 0
Study: 3407609

Group type: EXPERIMENTAL
Intervention: 15 mg beta-carotene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 45 mg beta-carotene
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-fat diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 45 mg beta-carotene (daily dosing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological doses of beta-carotene (45 and 90 mg)
Number of subjects: 0
Study: 764997

Group type: EXPERIMENTAL
Intervention: Trivalent vaccine (measles, mumps, rubella)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 31492048

Group type: EXPERIMENTAL
Intervention: Full Healthy Primary School of the Future (HPSF)
Number of subjects: 1676

Group type: EXPERIMENTAL
Intervention: Partial Healthy Primary School of the Future (HPSF)
Number of subjects: 1676

Group type: COMPARATOR
Intervention: Control Schools
Number of subjects: 1676
Study: 28289865

Group type: EXPERIMENTAL
Intervention: Pimasertib tablet (3 × 20 mg, PO QD)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Pimasertib capsule (2 × 30 mg, PO QD)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Overall disease control rate
Number of subjects: 38
Study: 25861647

Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance spectroscopy measurement after thoracentesis
Number of subjects: 45

Group type: COMPARATOR
Intervention: Bioelectrical impedance spectroscopy measurement before thoracentesis
Number of subjects: 45
Study: 23478893

Group type: EXPERIMENTAL
Intervention: Full-dose protocol (group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Half-dose protocol (group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LC-AS, HC-AS, and LC-FBP
Number of subjects: 100
Study: 21609974

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 761

Group type: COMPARATOR
Intervention: ICD
Number of subjects: 761
Study: 18082504

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 3491

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3491

Group type: EXPERIMENTAL
Intervention: Nonemergent PCI
Number of subjects: 3491
Study: 21320171

Group type: EXPERIMENTAL
Intervention: Platform switching with a 3.3 mm diameter abutment on test implants
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control implant with a straight 4 mm diameter abutment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison of test and control implants
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Crestal bone-level changes over time
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bacterial contamination in implants
Number of subjects: 25
Study: 15997246

Group type: EXPERIMENTAL
Intervention: Intensive diet and exercise intervention
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: 3'UTR Del/Del genotype
Number of subjects: 507